Y Sugiyama

1.1k total citations
27 papers, 912 citations indexed

About

Y Sugiyama is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Y Sugiyama has authored 27 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Y Sugiyama's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Asthma and respiratory diseases (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Y Sugiyama is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Asthma and respiratory diseases (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Y Sugiyama collaborates with scholars based in Japan and United States. Y Sugiyama's co-authors include Katsuhisa Oshikawa, Shin‐ichi Kanamitsu, Ken Ito, Yukiko Nakajima, Takeshi Iwatsubo, Ken Yanagisawa, Shoji Kudoh, Harumi Suzaki, Fumimaro Takaku and Hajime Maeda and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, The Annual Review of Pharmacology and Toxicology and European Respiratory Journal.

In The Last Decade

Y Sugiyama

25 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Sugiyama Japan 14 302 284 220 205 140 27 912
Michael Seiberling Switzerland 21 221 0.7× 166 0.6× 208 0.9× 133 0.6× 77 0.6× 45 1.6k
Chantal Le Guellec France 21 286 0.9× 134 0.5× 126 0.6× 111 0.5× 96 0.7× 59 1.3k
Ikuya Miki Japan 19 309 1.0× 123 0.4× 323 1.5× 83 0.4× 548 3.9× 65 1.1k
Parnian Zia‐Amirhosseini United States 11 112 0.4× 111 0.4× 178 0.8× 176 0.9× 111 0.8× 18 747
Margaret C. Shuhart United States 21 99 0.3× 291 1.0× 204 0.9× 205 1.0× 107 0.8× 32 1.6k
Salah‐Dine Chibout Switzerland 18 138 0.5× 122 0.4× 52 0.2× 232 1.1× 106 0.8× 40 1.1k
Robert R. LaBadie United States 21 191 0.6× 120 0.4× 171 0.8× 62 0.3× 58 0.4× 51 1.0k
Linyong Xu China 12 177 0.6× 93 0.3× 78 0.4× 55 0.3× 91 0.7× 35 740
T Horie Japan 10 247 0.8× 41 0.1× 159 0.7× 81 0.4× 131 0.9× 35 801
Justin Wilkins United States 17 201 0.7× 99 0.3× 64 0.3× 69 0.3× 147 1.1× 50 925

Countries citing papers authored by Y Sugiyama

Since Specialization
Citations

This map shows the geographic impact of Y Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Sugiyama more than expected).

Fields of papers citing papers by Y Sugiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Sugiyama. The network helps show where Y Sugiyama may publish in the future.

Co-authorship network of co-authors of Y Sugiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Y Sugiyama. A scholar is included among the top collaborators of Y Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Sugiyama. Y Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sugiyama, Y, Satoru Muro, Daisuke Ban, & Keiichi Akita. (2024). Retroperitoneal fasciae as barriers for nerve and arterial passages connecting the retroperitoneal region to the peritoneal organs. Journal of Anatomy. 245(1). 1–11. 4 indexed citations
3.
Uchibori, Ryosuke, Naoko Mato, Yoshihide Sehara, et al.. (2017). Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract. Gene Therapy. 24(5). 290–297. 28 indexed citations
4.
Takano, Junichi, Kazuya Maeda, Michael B. Bolger, & Y Sugiyama. (2016). The Prediction of the Relative Importance of CYP3A/P-glycoprotein to the Nonlinear Intestinal Absorption of Drugs by Advanced Compartmental Absorption and Transit Model. Drug Metabolism and Disposition. 44(11). 1808–1818. 34 indexed citations
5.
Mato, Naoko, Yoji Hakamata, Eiji Kobayashi, et al.. (2009). Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury. European Respiratory Journal. 33(6). 1415–1428. 13 indexed citations
6.
Soda, M, Shuji Takada, Kengo Takeuchi, et al.. (2009). Analysis of a Mouse Model for EML4-ALK -Positive Lung Cancer.. A2693–A2693.
7.
Tajima, Shunji, Masashi Bando, Yoshiki Ishii, et al.. (2008). Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice. European Respiratory Journal. 32(5). 1337–1343. 24 indexed citations
8.
Oshikawa, Katsuhisa, et al.. (2002). Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clinical & Experimental Allergy. 32(10). 1520–1526. 126 indexed citations
9.
Oshikawa, Katsuhisa, et al.. (2001). Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid. Respiratory Medicine. 95(6). 532–533. 33 indexed citations
10.
Bando, Masashi, Shoji Ohno, Katsuhisa Oshikawa, et al.. (2001). Infection of TT virus in patients with idiopathic pulmonary fibrosis. Respiratory Medicine. 95(12). 935–942. 47 indexed citations
11.
Ueda, Kaoru, Yukio Kato, Katsuko Komatsu, & Y Sugiyama. (2001). Inhibition of Biliary Excretion of Methotrexate by Probenecid in Rats: Quantitative Prediction of Interaction from in Vitro Data. Journal of Pharmacology and Experimental Therapeutics. 297(3). 1036–1043. 50 indexed citations
12.
Oshikawa, Katsuhisa & Y Sugiyama. (2000). Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer. Respiratory Medicine. 94(11). 1085–1091. 13 indexed citations
13.
Shibuya, Yasuhiro, T. Shiozaki, Mitsutoshi Hayashi, & Y Sugiyama. (2000). Efficacy of amplicor PCR for the diagnosis of tuberculosis in respiratory specimens other than sputum. Tubercle and Lung Disease. 80(4-5). 209–215. 2 indexed citations
14.
Sugiyama, Y, et al.. (1999). Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. European Respiratory Journal. 14(5). 1113–1116. 27 indexed citations
15.
Sugiyama, Y, K Saitoh, Shogo Kano, & Satoshi Kitamura. (1996). An autopsy case of diffuse panbronchiolitis accompanying rheumatoid arthritis. Respiratory Medicine. 90(3). 175–177. 5 indexed citations
16.
Sugiyama, Y, Tadashi Kasahara, Naofumi Mukaida, Koji Matsushima, & Satoshi Kitamura. (1995). Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis. European Respiratory Journal. 8(7). 1084–1090. 41 indexed citations
17.
Suga, Takashi, Y Sugiyama, Takeshi Fujii, & Satoshi Kitamura. (1994). Bronchioloalveolar carcinoma with bronchorrhoea treated with erythromycin. European Respiratory Journal. 7(12). 2249–2251. 12 indexed citations
18.
Sugiyama, Y, Shoji Kudoh, Hajime Maeda, Harumi Suzaki, & Fumimaro Takaku. (1990). Analysis of HLA Antigens in Patients with Diffuse Panbronchiolitis. American Review of Respiratory Disease. 141(6). 1459–1462. 100 indexed citations
19.
Matsumoto, Kunio, et al.. (1984). [Primary adenosquamous carcinoma of the stomach--a case report].. PubMed. 30(13). 1726–31. 3 indexed citations
20.
Kitamura, Satoshi, et al.. (1981). [Angiotensin I converting enzyme activity in patients with spontaneous pneumothorax and in rabbits with artificial pneumothorax (author's transl)].. PubMed. 19(9). 619–23. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Seiberling Breakdown of academic impact, for papers by Chantal Le Guellec Breakdown of academic impact, for papers by Ikuya Miki Breakdown of academic impact, for papers by Parnian Zia‐Amirhosseini Breakdown of academic impact, for papers by Margaret C. Shuhart Breakdown of academic impact, for papers by Salah‐Dine Chibout Breakdown of academic impact, for papers by Robert R. LaBadie Breakdown of academic impact, for papers by Linyong Xu Breakdown of academic impact, for papers by T Horie Breakdown of academic impact, for papers by Justin Wilkins
Rankless by CCL
2026